FGEN
Income statement / Annual
Last year (2023), FibroGen, Inc.'s total revenue was $147.75 M,
an increase of 4.99% from the previous year.
In 2023, FibroGen, Inc.'s net income was -$284.23 M.
See FibroGen, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$147.75 M
|
$140.73 M
|
$235.31 M
|
$176.32 M
|
$256.58 M
|
$212.96 M
|
$125.67 M
|
$179.58 M
|
$180.83 M
|
$137.60 M
|
| Cost of Revenue |
$18.85 M |
$20.28 M |
$12.87 M |
$8.87 M |
$1.15 M |
$235.84 M |
$196.52 M |
$187.21 M |
$214.09 M |
$150.79 M |
| Gross Profit |
$128.90 M |
$120.45 M |
$222.44 M |
$167.45 M |
$255.43 M |
-$22.88 M |
-$70.85 M |
-$7.63 M |
-$33.26 M |
-$13.19 M |
| Gross Profit Ratio |
0.87 |
0.86 |
0.95 |
0.95 |
1 |
-0.11 |
-0.56 |
-0.04 |
-0.18 |
-0.1 |
| Research and Development
Expenses |
$282.86 M
|
$296.79 M
|
$387.04 M
|
$252.92 M
|
$209.27 M
|
$235.84 M
|
$196.52 M
|
$187.21 M
|
$214.09 M
|
$150.79 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$63.81 M
|
$51.76 M
|
$46.03 M
|
$44.36 M
|
$36.91 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$115.25 M
|
$124.69 M
|
$123.93 M
|
$106.41 M
|
$135.48 M
|
$63.81 M
|
$51.76 M
|
$46.03 M
|
$44.36 M
|
$36.91 M
|
| Other Expenses |
$12.61 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$42.16 M |
$0.00 |
$0.00 |
$0.00 |
$16,000.00 |
| Operating Expenses |
$398.11 M |
$421.48 M |
$510.97 M |
$359.33 M |
$344.74 M |
$299.65 M |
$248.28 M |
$233.23 M |
$258.45 M |
$187.70 M |
| Cost And Expenses |
$429.57 M |
$441.76 M |
$523.84 M |
$368.20 M |
$345.89 M |
$299.65 M |
$248.28 M |
$233.23 M |
$258.45 M |
$187.70 M |
| Interest Income |
$10.48 M |
$7.60 M |
$1.01 M |
$5.55 M |
$15.55 M |
$11.57 M |
$6.43 M |
$2.63 M |
$3.12 M |
$1.69 M |
| Interest Expense |
$15.53 M |
$1.44 M |
$2.15 M |
$2.40 M |
$2.88 M |
$10.99 M |
$9.71 M |
$10.73 M |
$11.03 M |
$11.11 M |
| Depreciation &
Amortization |
$9.93 M
|
$10.60 M
|
$14.81 M
|
$22.05 M
|
$21.45 M
|
$6.56 M
|
$6.10 M
|
$6.04 M
|
$5.68 M
|
$4.47 M
|
| EBITDA |
-$261.41 M
|
-$282.83 M
|
-$274.80 M
|
-$164.28 M
|
-$52.31 M
|
-$68.56 M
|
-$104.75 M
|
-$44.99 M
|
-$68.83 M
|
-$43.93 M
|
| EBITDA Ratio |
-1.77 |
-2.01 |
-1.23 |
-1.06 |
-0.29 |
-0.35 |
-0.92 |
-0.25 |
-0.41 |
-0.32 |
| Operating Income Ratio
|
-1.91
|
-2.14
|
-1.23
|
-1.09
|
-0.35
|
-0.41
|
-0.98
|
-0.3
|
-0.43
|
-0.36
|
| Total Other
Income/Expenses Net |
-$5.05 M
|
$6.16 M
|
-$2.15 M
|
$2.95 M
|
$12.67 M
|
$577,000.00
|
-$3.27 M
|
-$8.10 M
|
-$7.91 M
|
-$9.40 M
|
| Income Before Tax |
-$286.87 M |
-$294.87 M |
-$290.68 M |
-$188.93 M |
-$76.64 M |
-$86.12 M |
-$125.88 M |
-$61.75 M |
-$85.54 M |
-$59.50 M |
| Income Before Tax Ratio
|
-1.94
|
-2.1
|
-1.24
|
-1.07
|
-0.3
|
-0.4
|
-1
|
-0.34
|
-0.47
|
-0.43
|
| Income Tax Expense |
$3,000.00 |
$358,000.00 |
$347,000.00 |
$360,000.00 |
$328,000.00 |
$304,000.00 |
$321,000.00 |
-$71,000.00 |
$242,000.00 |
$11.12 M |
| Net Income |
-$284.23 M |
-$295.23 M |
-$291.03 M |
-$189.29 M |
-$76.97 M |
-$86.42 M |
-$126.20 M |
-$61.68 M |
-$85.78 M |
-$59.50 M |
| Net Income Ratio |
-1.92 |
-2.1 |
-1.24 |
-1.07 |
-0.3 |
-0.41 |
-1 |
-0.34 |
-0.47 |
-0.43 |
| EPS |
-2.92 |
-3.15 |
-3.15 |
-2.11 |
-0.89 |
-1.03 |
-1.73 |
-0.98 |
-1.42 |
-3.17 |
| EPS Diluted |
-2.92 |
-3.15 |
-3.15 |
-2.11 |
-0.89 |
-1.03 |
-1.73 |
-0.98 |
-1.42 |
-3.17 |
| Weighted Average Shares
Out |
$97.30 M
|
$93.58 M
|
$92.35 M
|
$89.85 M
|
$86.63 M
|
$84.06 M
|
$72.99 M
|
$62.74 M
|
$60.34 M
|
$18.78 M
|
| Weighted Average Shares
Out Diluted |
$97.30 M
|
$93.58 M
|
$92.35 M
|
$89.85 M
|
$86.63 M
|
$84.06 M
|
$72.99 M
|
$62.74 M
|
$60.34 M
|
$18.78 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
